Testimony

FDA Meeting – Agile Transdermal Contraceptive Patch AG200-15

By Sarah Christopherson | Oct 30, 2019 | Comments Off on FDA Meeting – Agile Transdermal Contraceptive Patch AG200-15

Testimony Delivered at the Meeting of the FDA Bone, Reproductive and Urologic Drugs Advisory Committee

FDA Comments- Makena

By Cindy Pearson | Oct 29, 2019 | Comments Off on FDA Comments- Makena

[FDA-2019-N-4203] To Whom It May Concern: The National Women’s Health Network (NWHN) is a nonprofit advocacy organization that works to improve the health of all women. We are supported by our members and by choice, we do not accept financial…

FDA Comments – Draft Guidance for Hormonal Contraceptive Products

By Sarah Christopherson | Sep 10, 2019 | Comments Off on FDA Comments – Draft Guidance for Hormonal Contraceptive Products

Public comments on FDA guidance for the development of new, safe and effective hormonal contraceptive products.

FDA Meeting – Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse 

By Cindy Pearson | Feb 12, 2019 | Comments Off on FDA Meeting – Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse 

Testimony Delivered at the Meeting of the FDA Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee

FDA Meeting – Risk Benefit Assessment

By Caila Brander | Sep 18, 2017 | Comments Off on FDA Meeting – Risk Benefit Assessment

Testimony Delivered at the FDA Public Meeting on Benefit-Risk Assessments in Drug Regulatory Decision-Making

FDA Meeting – Off-Label Use of Medical Products

By Sarah Christopherson | Nov 9, 2016 | Comments Off on FDA Meeting – Off-Label Use of Medical Products

Testimony Delivered at the FDA Public Meeting on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products

FDA Comments – Real World Evidence & Essure

By Shaniqua Seth | Oct 14, 2016 | Comments Off on FDA Comments – Real World Evidence & Essure

Comments on the Draft Guidance: Use of Real-World Evidence to Support Regulatory Decision Making for Medical Devices

FDA Meeting – Clinical Trial Diversity

By Sarah Christopherson | Feb 29, 2016 | Comments Off on FDA Meeting – Clinical Trial Diversity

Food and Drug Administration Safety and Innovation Act 907 Public Meeting: Progress on Enhancing the Collection, Analysis, and Availability of Demographic Subgroup Data

FDA Scientific Workshop – Labeling of Low-Dose Vaginal Estrogen Products

By Cindy Pearson | Nov 13, 2015 | Comments Off on FDA Scientific Workshop – Labeling of Low-Dose Vaginal Estrogen Products

Food and Drug Administration Scientific Workshop on Labeling Lower-Dose Estrogen-Alone Products for Symptoms of Vulvar and Vaginal Atrophy

FDA Scientific Workshop – Drug Interactions With Hormonal Contraceptives

By Christina Cherel | Nov 9, 2015 | Comments Off on FDA Scientific Workshop – Drug Interactions With Hormonal Contraceptives

Food and Drug Administration Hormonal Contraception Public Workshop on Drug Interactions with Hormonal Contraceptives: Public Health and Drug Development Implications